Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News
  • Offerings

Hess Midstream LP Announces Secondary Public Offering Of 10M Class A Shares

By Benzinga Newsdesk
February 5, 5:22 PM
Hess Midstream LP (NYSE:HESM) ("HESM") today announced the commencement of an underwritten public offering of an aggregate of 10,000,000 Class A shares representing limited partner interests in HESM by an affiliate of

HESM

Read More
1 minute read
  • News
  • Offerings

4D Molecular Therapeutics Announces $250M Proposed Public Offering Of Common Stock

By Benzinga Newsdesk
February 5, 5:16 PM
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, announced today that it has

FDMT

Read More
1 minute read
  • News
  • Offerings

Immix Biopharma Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

By Benzinga Newsdesk
February 5, 4:21 PM
Immix Biopharma, Inc. (NASDAQ:IMMX) (the "Company"), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it intends to offer and sell shares of its common

IMMX

Read More
1 minute read
  • News
  • Offerings

Intelligent Bio Solutions Inc. Announces Exercise Of Previously Issued Warrants For $1.77M In Gross Proceeds

By Benzinga Newsdesk
February 5, 10:09 AM
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company

INBS

Read More
1 minute read
  • News
  • Offerings

The Cigna Group Announces Commencement Of Tender Offers For Up To $2.25B In Aggregate Principal Amount Of Outstanding Notes

By Benzinga Newsdesk
February 5, 9:27 AM
The Cigna Group (NYSE:CI) announced today that it has commenced tender offers to purchase for cash (1) any and all of The Cigna Group's (the "Company") 3.50% Senior Notes due 2024 and Evernorth Health, Inc.'s

CI

Read More
1 minute read
  • After-Hours Center
  • Financing
  • Movers
  • News
  • Offerings

Rocket Lab Stock Is Spiraling Lower: What’s Going On?

By Adam Eckert
January 31, 5:54 PM
Rocket Lab USA Inc (RKLB) shares are trading lower in Wednesday's after-hours session after the company announced a proposed offering.

RKLB

Read More
2 minute read
  • Movers
  • News
  • Offerings

Sidus Space Stock Is Tumbling Tuesday: What’s Going On?

By Adam Eckert
January 30, 9:53 AM
Sidus Space Inc (NASDAQ:SIDU) shares are trading lower Tuesday after the company announced a proposed public offering.

SIDU

Read More
2 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Offerings
  • Trading Ideas

Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

By Vandana Singh
January 30, 7:27 AM
Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy.

GILD

Read More
1 minute read
  • News
  • Offerings

TD SYNNEX Announces Launch of Secondary Public Offering of 7.4M Common Stock and Concurrent Share Repurchase of up to $160M by Selling Stockholders

By Benzinga Newsdesk
January 29, 7:45 AM
TD SYNNEX Corporation (NYSE:SNX) ("TD SYNNEX" or the "Company") today announced a proposed secondary public offering of 7,375,000 shares of its common stock currently held by certain entities managed

SNX

Read More
1 minute read
  • Equities
  • General
  • Management
  • Movers
  • News
  • Offerings

Why Nuvve Holding Shares Are Falling Friday

By Nabaparna Bhattacharya
January 26, 2:56 PM
Nuvve Holding shares decline as the company files for a public offering of 2.3 million shares and amends CEO Gregory Poilasne's employment agreement. Nuvve's stock has been facing roller-coaster ride amid recent reverse stock split, $16 million project win, among others.

NVVE

Posts pagination

Previous 1 … 19 20 21 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service